Skip to content

Clinical trials

Phase 2 Leukemia, Myelomonocytic, Chronic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Phase: Phase 2 Country / region: Italy Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20101
20161
20191
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting1
Enrolling by invitation1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cogent Biosciences, Inc.1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione Italiana Sindromi Mielodisplastiche-ETS1
Fred Hutchinson Cancer Center1
Janssen Research & Development, LLC1
Millennium Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic8
Leukemia, Myeloid, Acute5
Myelodysplastic Syndromes5
Myeloproliferative Disorders3
Burkitt Lymphoma2
Hodgkin Disease2
Immunoblastic Lymphadenopathy2
Intraocular Lymphoma2
Leukemia, Biphenotypic, Acute2
Leukemia, Hairy Cell2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.